首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >Synaptic transmission block by presynaptic injection of oligomeric amyloid beta
【2h】

Synaptic transmission block by presynaptic injection of oligomeric amyloid beta

机译:突触前注射寡聚淀粉样蛋白β阻断突触传递

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Early Alzheimer's disease (AD) pathophysiology is characterized by synaptic changes induced by degradation products of amyloid precursor protein (APP). The exact mechanisms of such modulation are unknown. Here, we report that nanomolar concentrations of intraaxonal oligomeric (o)Aβ42, but not oAβ40 or extracellular oAβ42, acutely inhibited synaptic transmission at the squid giant synapse. Further characterization of this phenotype demonstrated that presynaptic calcium currents were unaffected. However, electron microscopy experiments revealed diminished docked synaptic vesicles in oAβ42-microinjected terminals, without affecting clathrin-coated vesicles. The molecular events of this modulation involved casein kinase 2 and the synaptic vesicle rapid endocytosis pathway. These findings open the possibility of a new therapeutic target aimed at ameliorating synaptic dysfunction in AD.
机译:早期阿尔茨海默氏病(AD)的病理生理学特征是淀粉样前体蛋白(APP)降解产物引起的突触变化。这种调制的确切机制尚不清楚。在这里,我们报道了纳摩尔浓度的轴突内寡聚(o)Aβ42,而不是oAβ40或细胞外oAβ42,可在鱿鱼巨型突触处急性抑制突触传递。该表型的进一步表征表明,突触前钙电流不受影响。然而,电子显微镜实验显示,在oAβ42显微注射的末端,对接的突触囊泡减少了,而不会影响网格蛋白包被的囊泡。该调节的分子事件涉及酪蛋白激酶2和突触小泡快速内吞途径。这些发现打开了旨在改善AD中突触功能障碍的新治疗靶标的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号